We use cookies to offer a better browsing experience, analyze site traffic, personalize content, and serve targeted advertisements. By clicking accept, you consent to our privacy policy & use of cookies. (Privacy Policy)

Rolls Royce Share Price Gains 1.3% On New COVID-19 Vaccine Transport Collaboration

Avatar photo
Eno Eteng (MSTA) Investment writer, Certified Financial Technician
    Summary:
  • Rolls Royce share price adds 1.3% after the company announced the development of a new COVID-19 vaccine transport system in collaboration with ChefsFridge.

The bullish move of Rolls Royce share price by 1.29% makes this stock one of the top 6 gainers on the FTSE 100 index this Tuesday. 

After an initially lower opening by the stock, the Rolls Royce share price bounced back into positive territory as it announced a collaboration with ChefsFridge to design cold pods to be used to transport COVID-19 vaccines globally. 

The new product, which will be designed using ArcticRx, is the first product of its kind that will be built to support a double-dose vaccine delivery system within the cold chain. Specifically built to target remote, hard-to-reach areas and countries with power supply challenges, the product could be a game-changer in cold chain vaccine transport.

Investors cheered the news and Rolls Royce shares saw fresh demand late in the London session, putting it on course for a second consecutive higher close.

Rolls Royce Share Price Outlook

Tuesday’s intraday bounce from the 95.05 support allows the pair to target the 99.90 resistance. A continued advance allows the pair to hit the 103.63 price mark before 110.05 becomes available as the next upside barrier.

On the flip side, a brea down of 95.05 opens the door for sellers to attempt a push towards 90.52, below which 86.40 (26 January low) becomes another potential downside target. Price descent below this level forms new lows for 2021.

Rolls Royce: Daily Chart

Follow Eno on Twitter.